https://nl.marketscreener.com/koers/aandeel/SYROS-PHARMACEUTICALS-INC-29688130/nieuws/Syros-presenteert-eerste-veiligheidsgegevens-van-SELECT-AML-1-Trial-waarin-Tamibarotene-wordt-geeva-42522953/?utm_source=telegram&utm_medium=social&utm_campaign=share